<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05114564</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-129</org_study_id>
    <nct_id>NCT05114564</nct_id>
  </id_info>
  <brief_title>Evaluation of The Performance of Monthly Replacement Sphere Lens Deigns in Habitual Soft Contact Lens Wearers</brief_title>
  <official_title>Evaluation of The Performance of Monthly Replacement Sphere Lens Deigns in Habitual Soft Contact Lens Wearers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the clinical performance of two monthly silicone&#xD;
      hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn&#xD;
      for 1-month.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, bilateral eye, double-masked, randomized, 1-month cross-over,&#xD;
      daily-wear design involving two different FRP lens types. Each lens type will be worn for&#xD;
      approximately one month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">April 12, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 16, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Ratings on Lens handling on removal</measure>
    <time_frame>Day 27</time_frame>
    <description>Subjective Ratings on Lens handling on removal (0-10 scale, 0.5 steps; 0- very easy, 10 -very difficult)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Lens A (Test)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be randomized to wear test lenses for one month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lens B (Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be randomized to wear control lenses for one month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lens A (Test)</intervention_name>
    <description>Test Lens A</description>
    <arm_group_label>Lens A (Test)</arm_group_label>
    <arm_group_label>Lens B (Control)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control Lens B</intervention_name>
    <description>Control Lens B</description>
    <arm_group_label>Lens A (Test)</arm_group_label>
    <arm_group_label>Lens B (Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Is at least 18 years of age and no older than 35 years, and has full legal capacity to&#xD;
             volunteer;&#xD;
&#xD;
          -  Has read and signed an information consent letter;&#xD;
&#xD;
          -  Is willing and able to follow instructions and maintain the appointment schedule;&#xD;
&#xD;
          -  Self-reports having a full eye examination in the previous two years;&#xD;
&#xD;
          -  Self-reports spending on most days at least 6 hours cumulative (not necessarily in one&#xD;
             single stretch) using digital devices such as a computer, laptop, tablet, e-reader,&#xD;
             smart- phone;&#xD;
&#xD;
          -  Has healthy eyes with no health condition or medication that contra-indicate contact&#xD;
             lens wear, in the opinion of the investigator;&#xD;
&#xD;
          -  Anticipates being able to wear the study lenses for at least 8 hours a day, 6 days a&#xD;
             week;&#xD;
&#xD;
          -  Habitually wears soft frequent replacement contact lenses, for the past 3 months&#xD;
             minimum (NOTE: the habitual contact lens brand is restricted such that no more than&#xD;
             one third are to be the Biofinity brand (or their equivalent private label brand name)&#xD;
             and no more than one third are to be an Alcon brand;&#xD;
&#xD;
          -  Has refractive astigmatism no higher than -0.75DC in each eye;&#xD;
&#xD;
          -  Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available&#xD;
             lens parameters are sphere +6.00 to -6.00D, 0.25D steps).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Is participating in any concurrent clinical or research study;&#xD;
&#xD;
          -  Has any known active* ocular disease and/or infection that contraindicates contact&#xD;
             lens wear;&#xD;
&#xD;
          -  Has a systemic or ocular condition that in the opinion of the investigator may affect&#xD;
             a study outcome variable;&#xD;
&#xD;
          -  Is using any systemic or topical medications that in the opinion of the investigator&#xD;
             may affect contact lens wear or a study outcome variable;&#xD;
&#xD;
          -  Has known sensitivity to the diagnostic sodium fluorescein used in the study;&#xD;
&#xD;
          -  Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;&#xD;
&#xD;
          -  Has undergone refractive error surgery or intraocular surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shane Foster</last_name>
    <role>Principal Investigator</role>
    <affiliation>Athens Eye Care,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Sacco</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sacco Eye Group PLLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gina Wesley</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complete Eye Care of Medina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katherine Bickle</last_name>
    <role>Principal Investigator</role>
    <affiliation>ProCare Vision Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Vega</last_name>
    <phone>19256213761</phone>
    <email>JVega2@coopervision.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Complete Eye Care of Medina</name>
      <address>
        <city>Minnesota</city>
        <state>Minnesota</state>
        <zip>55364</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Gina Wesley</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sacco Eye Group PLLC,</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <zip>13850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Athens Eye Care</name>
      <address>
        <city>Athens</city>
        <state>Ohio</state>
        <zip>45701</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shane Foster</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ProCare Vision Center</name>
      <address>
        <city>Granville</city>
        <state>Ohio</state>
        <zip>43023</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Katherine Bickle</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

